A new study at Rice University asked whether drivers understand cyclist hand signals. The research was led by a doctoral student in psychological sciences.
In the study, drivers watched realistic road scenes and were asked to predict whether a cyclist would turn left, turn right, stop or go straight. Each scene combined three cues: arm signals, head movement and the cyclist's position on the road.
Drivers relied mostly on arm signals. Lane position and a glance over the shoulder did not improve predictions much. Eye tracking showed drivers looked at the cyclist's back first, then at the arms or head. Simulated phone conversations made drivers worse. The researchers say clearer signals and better education are needed.
Difficult words
- study — a careful examination or research project
- predict — to say what will happen next
- signal — a movement or sign that gives informationarm signals, clearer signals
- position — the place of something on the roadLane position, cyclist's position
- eye tracking — a method that records where people look
- simulate — to make something seem like the real thingSimulated phone conversations
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you seen cyclists use hand signals on the road? Describe one example.
- How can drivers learn to understand cyclist signals better?
Related articles
Targeting a brain circuit to reduce opioid relapse
Researchers at Washington State University found that lowering activity in a specific brain connection cut heroin-seeking in a preclinical model. The study identifies a pathway between the prelimbic cortex and the paraventricular thalamus and tests two ways to reduce its activity.
New device measures blood viscosity in real time
Researchers at the University of Missouri created a non-invasive device that monitors blood viscosity and density in real time using ultrasound and software. It can read blood without drawing samples and may help in diseases like sickle cell.
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.